Object. For decades the gold standard for reconstructing a large peripheral nerve defect has been, and remains, the nerve autograft. Alternatives to the nerve autograft include biological conduits and vessels. Adding stem cells in the lumen of a nerve conduit has been the subject of multiple studies. The purpose of the present meta-analysis was to summarize animal experimental studies on the effect of stem cells as a luminal additive when reconstructing a peripheral nerve defect with a nerve graft.
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P eriPheral nerve trauma is a disabling injury with an incidence of 2.8% in trauma patients. 35 Reconstructing the lacerated or injured nerve stumps using a direct end-to-end technique without any tension results in the best recovery. If a gap between both nerve ends cannot be bridged without tension, a graft or guide should be used. For decades the autologous nerve graft has been the gold standard, 8 and while this still is the case, using a donor nerve as a nerve graft has several limitations. The most apparent limitation is the need for a secondary surgical intervention with corresponding donorsite morbidity, and consequently symptoms, such as loss of sensibility (hypesthesia), scar formation, and possible neuroma formation, can arise. The prolonged duration of the surgery and the limited donor nerve length are also limitations that should not be underestimated when using a donor nerve. 38 Due to the aforementioned limitations of nerve grafts, experimental research has focused on the use of alternative conduits. Materials used are biological (muscle, artery, vein, and tendon), nondegradable (silicone tube), and biodegradable synthetic materials (collagen, polyglycolic acid, polyesters, copolyesters, and chitosan). 1, 43 In recent years, within this field, the introduction of supporting growth factors and other cells has received increased interest, aiming to supply substitutes that promote nerve regeneration. A few examples of these additives uses are nerve growth factor, Schwann cells, and several types of The effect of stem cells in bridging peripheral nerve defects: a meta-analysis stem cells. 4, 15, 34, 36, 47, 56 A number of different types of stem cells have been used in animal experiments focusing on nerve regeneration in a nerve reconstruction model. Bone marrow stromal cells (BMSCs), adipose-derived stromal cells (ADSCs), hair follicle stem cells, skin-derived mesenchymal stem cells, and amniotic fluid-derived mesenchymal stem cells can all be applied. 23, 31, 36, 37, 47 The different stem cells have different advantages and disadvantages. Stem cells, such as BMSCs of mesenchymal origin, can differentiate successfully into neural cells. 13 The BMSCs, in particular, can be easily harvested from bones, and with their apparent plasticity they can transdifferentiate into a Schwann cell-like phenotype. 48 Another theory, however, regarding the beneficial effect of BMSCs is that they function as growth promoting factors. 34 ADSCs are less invasive to harvest as they can be derived from belly fat or other adipocyte-containing tissue. They have a comparable phenotypic profile as the BMSCs, and some studies have even indicated that ADSCs have a more profound tendency to transdifferentiate into a Schwann cell-like phenotype. 36 More recently applied stem cells, such as hair follicle pluripotent stem cells and skin-derived stem cells, are also easily accessible and can transdifferentiate into Schwann cell-like cells as well. 23 Although most studies investigating the use of stem cell to enhance nerve regeneration have expressed enthusiasm and have promoted further research, 25 ,31 researchers have not compared their own data to other studies, nor has anyone proposed an evaluation protocol that would allow a correct comparison of the results. Therefore, the purpose of this meta-analysis is to summarize the effect of different types of stem cells in animal experimental studies used to enhance regeneration after reconstructing a peripheral nerve injury.
Methods
Following PRISMA guidelines this meta-analysis was conducted by 3 reviewers who examined each reference and determined study eligibility. The ARRIVE guideline was not used.
Criteria for Included Studies
The criteria for inclusion and exclusion of studies are depicted in Table 1 .
Search Method for Identification of Studies
A literature search of MEDLINE and Embase databases (from inception to April 2012) was performed with assistance of a professional librarian. The following terms were applied: nerve reconstruction, repair, injury, transection, regeneration, and stem cells (different kinds of stem cells) in animal experiments (the full set of search terms is presented in Fig. 1 ). Three reviewers (C.H., T.N., and B.M.) independently examined all articles by reading the title, and when the title seemed relevant, the abstract was examined. Disagreement about the inclusion or exclusion of articles was resolved by consensus. When multiple journals published the same study, or parts of the same study, only one study was included and multiple reports of the same study were merged together. A flow chart of the included studies is presented in Fig. 2 .
Data Collection and Extraction
After examination of the included studies, data were extracted. Collected characteristics were the following: study design; sample size; animal weight, sex, age, species, and strain; stem cell type; scaffold type; peripheral nerve; gap length; assessment modality; and follow-up time. The collected outcome data were as follows: Sciatic Functional Index (SFI), the muscle mass ratio (MM), and electrophysiological parameters (nerve conduction velocity, amplitude, and latency). If data were presented in graphs or figures only, values were estimated using the Adobe Photoshop CS5 measure tool. Data were entered in ReviewManager version 5.1 for further examination and analysis (http:// tech.cochrane.org/revman/about-revman-5). Characteristics of included studies are shown in Table 2 , and data of the included studies are summarized in Table 3 .
Data and Statistical Analysis
Data analysis was performed using ReviewManager. Since the primary objective was to analyze the effect of stem cells on nerve regeneration, 2 groups needed to be compared. In both groups, the nerve defect should have been bridged with a conduit, but only one group should have received the cellular therapy. Because of discrepancy and inconsistencies, not all outcome measurements could be used for analysis. Based on the frequency of the outcome measurement, 3 different outcome measurements were chosen for analysis: the SFI, the MM, and electrophysiology. These 3 outcome measurements were all functional analysis tools, whereas histology, for instance, differed too much across studies to allow us to summarize the results in a meta-analysis. From the included outcome measures, forest plots were created (Figs. [3] [4] [5] . The SFI is a measurement that can be derived from the walking track analysis and is displayed in values ranging from 0 (good) to 100 (no function). 3 The MM, or gastrocnemius muscle index, is calculated by comparing the muscle mass of the operated leg with the muscle mass in the nonoperated leg. The electrophysiology parameters are obtained by applying electrical stimulation at the nerve trunk proximal to the nerve graft and at the dis- The data were categorized into 3 subgroups according to 3 different follow-up periods: less than 1 month (the "short" follow-up time), between 1 and 3 months (the "middle" follow-up time), and more than 3 months (the "long" follow-up time). The studies were arranged by ascending gap length. The model used for the meta-analysis was the random-effects model. The variability of the measured effect was based on the width of the confidence interval and the number of animals per group. Effect sizes are expressed as standard mean differences between both groups (experimental and control) with its confidence interval. The variability of the overall measured effect was used as the weight for calculating the overall summarized effect of each subgroup. Subgroup statistics were calculated for the different end points.
Results

Literature Search
A total of 4156 articles were found in the 2 databases (1401 in MEDLINE and 2755 in Embase). After discarding duplicates, 3362 articles were assessed. Screening excluded 3238 records, leaving 124 articles for which the full text was obtained. One hundred one full-text articles were assessed for eligibility, and 31 studies were excluded based on their intervention. Finally, 69 studies from 70 reports were included for final selection. Based on the outcome measurements set prior to the selection, data from 44 studies from 45 reports were eventually used for meta-analysis. Of these, 27 studies investigated BMSCs, 7 ADSCs and 12 other types of stem cells. The flow diagram of the search selection is presented in Fig. 2 .
Functional Outcome Measurements
From the forest plot in Fig. 3 , it can be seen that all stem cells had a significant positive effect on the SFI for the 3 different follow-up periods compared with the control group. More specifically, at the 3 serial follow-up times the mean difference in SFI after tube-assisted nerve reconstruction in the BMSC group compared with the control group was 16.3 (95% CI 15.6-16.9), 14.2 (95% CI 13.6-14.9), and 21.48 (95% CI 20.4-22.6), respectively. The ADSC group showed a mean difference compared with the control group at the three follow-up times of 1.4 (95% CI 1.0-1.8), 8 .0 (95% CI 7.7-8.3) and 6.3 (95% CI 6.1-6.6), respectively. The mean difference, compared with the control group, found in the other stem cell group was 12.3 (95% CI 11.5-13.1), 1.9 (95% CI 1.9-1.9), and 9.8 (95% CI 9.2-10.4).
The forest plots of the MM, or gastrocnemius muscle index, for 2 follow-up periods (< 3 months and ≥ 3 months) showed a significant positive effect in all stem cell groups compared with their control groups. The mean differences in the BMSC group compared with the control group at the 2 follow-up times were 5.0% (95% CI 4.0%-6.1%) and 4.0% (95% CI 2.9%-5.1%). A mean difference at the longer follow-up time (≥ 3 months) of 9.0% (95% CI 6.8%-11.2%) was shown in the ADSC group compared with the control group. The effect of the other stem cells (stromal vascular fraction) was based on only one study and showed a mean difference of 40.6% (95% CI 23.9%-57.4) at the long follow-up time.
Regarding the electrophysiology, all stem cell groups showed significant positive effects compared with the control groups for the 2 follow-up periods (middle and late), except for the NCV of "other" stem cells in the longer follow-up period. The forest plots are depicted in Fig.  5 . The mean difference in the BMSC group showed a significant positive effect on the NCV at the 2 follow-up times of 4.7 mm/msec (95% CI 4.2-5.3 mm/msec) and 1.9 mm/msec (1.1-2.7 mm/msec). The mean differences in amplitude were 1.9 mV (95% CI 1.6-2.2 mV) and 0.3 mV (95% CI 0.2-0.4 mV) in the 2 follow-up times. The latency showed a mean difference of -0.4 msec (95% CI -0.4 to -0.3 msec) and -1.3 msec (95% CI -2.1 to -0.6 msec), compared with the control group.
In the ADSC group compared with controls, for the longest of the follow-up times, the mean difference in NCV showed a significant positive difference of 2.9 mm/ msec (95% CI 2.6-3.3 mm/msec); the mean difference in amplitude was 3.9 mV (95% CI 3.6-4.2 mV); and the mean difference in latency was -0.6 msec (95% CI -0.6 to -0.5 msec).
The mean difference when comparing the other stem cell group (amniotic fluid-derived stem cells and skinderived stem cells) with the control group showed a positive effect on the NCV at the 2 follow-up times of 1.0 mm/msec (95% CI 0.2-1.9 mm/msec) and -6.2 mm/msec (95% CI -7.2 to -5.2 mm/msec). The mean difference in amplitude was 0.1 mV (95% CI 0.0-0.1 mV) at the middle follow-up time and 6.0 (95% CI 2.1-9.9) at the long follow-up time. The effect of the other stem cells on the latency was based on only one study and showed a mean difference of -0.8 msec (95% CI -1.2 to -0.4 msec) at the middle follow-up time. 
Discussion
This meta-analysis aimed to summarize the beneficial regenerative effect of the different types of stem cells, comparing animal studies of treatment groups (nerve reconstruction using a nerve guide augmented with stem cells) and a control group (nerve reconstruction without the support of stem cells). With respect to functional outcome, the contribution of stem cells is apparent and thus suffices as an even better neuronal regeneration. The regeneration effect is summarized for 3 different functional outcome measurements.
The first outcome measurement evaluated was the SFI. The SFI showed significantly better results in all stem cell groups than the control group for the different follow-up periods. Since the SFI is derived from the walking track analysis, which is a valid tool for evaluating the regeneration of the nerve, the positive effect found in all studies using this technique is strong evidence for the supporting role of stem cells. 3 The second functional outcome, the MM, or the gastrocnemius muscle index, also showed positive results for both the ADSCs and BMSCs. For the ADSCs (n = 7 studies) and BMSCs (n = 27 studies), multiple studies were used in this analysis. Like the SFI, the MM and the gastrocnemius muscle index are also valid, well-accepted tools for evaluating nerve regeneration. The standardized protocol for assessing the muscle mass allows an easy comparison among the different studies.
The third functional outcome measurement is electrophysiology. Using electrophysiology, nerve conduction latency, amplitude, and velocity can be recorded. The mean differences showed the beneficial effect of the BMSCs and the ADSCs for all 3 parameters in the 3 different follow-up periods. The other stem cells (amniotic fluid-derived stem cells and the skin-derived stem cells) exhibited a positive effect for the 3 different measurements for both the latency and amplitude in the 3 different follow-up periods. It was only in the evaluation of nerve conduction velocity in the long follow-up period that no significant beneficial effect of the intraluminal injection of other stem cells (amniotic fluid-derived stem cells and the skin-derived stem cells) was found.
Interpretation of Results
Some studies investigated the survival of stem 
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cells in the graft. 12 The main conclusion was that the cells survived in follow-up periods of up to 3 months. 40, 48 The proportion of cells that survived was reported to be up to 38%. 42 Furthermore, the transition from stem cell to Schwann cell has been encountered previously and thus indicates that this could be a vital factor in explaining the beneficial effect. 6, 7, 39, 45 Schwann cells, however, not only myelinate; Höke et al. 14 showed that the Schwann cell phenotype can be modulated, for example, into motor or sensory Schwann cells. Also, the stem cells offer a more supporting and productive role, producing neural growth stimulating factors.
7,39
Limitations
This study has a number of limitations. The first limitation is that the duration of investigation for the different types of stem cells varies significantly. BMSCs are subject to investigation for a longer period of time than, for example, hair follicle-derived stem cells. As can therefore be expected, the number of articles used for analysis for the different types of cells varies and possibly accounts for the differences in regenerative effect.
Regarding the evaluation tools used, it should be noted that some studies evaluated nerve regeneration at multiple time points by using the walking track analysis to determine the SFI. To allow a comparison among all included studies, we decided to set a maximum of 3 end points for this evaluation. For the other 2 outcome measurements, muscle mass and electrophysiology, only 1 end point was used. When a study compared 2 experimental groups with 1 control group, the data of this control group were used twice in the analysis. This made the actual sample size of the control group smaller than the factual one.
Implications
The studies investigated in this meta-analysis were all animal-related studies and do not guarantee success in the clinical setting. Although multiple studies have been conducted and stimulate the use of stem cells for nerve reconstruction, the bridge to clinical implementation has yet to be made. At this point, undoubtedly strong evidence is presented for the beneficial effect of the stem cells. Therefore, the present study can help progress the translational approach for implementing stem cells in further clinical research. The focus of the present study was on the beneficial effect of stem cells on nerve regeneration. A future step could be to compare the overall effect of the stem cells to the regeneration after reconstructing a peripheral nerve defect with a nerve autograft.
Conclusions
This is the first meta-analysis performed in the field of experimental nerve reconstruction to illustrate a beneficial effect of stem cells used as a luminal additive. Taking our findings into consideration, we may conclude that reconstructing a peripheral nerve gap using a guide with a luminal additive (that is, cellular therapy) results in better regeneration compared with using a conduit alone.
